Lv31
396 积分 2023-04-13 加入
Add-On Treatment With Zilebesiran for Inadequately Controlled Hypertension
18天前
已关闭
CDK inhibitors from past to present: A new wave of cancer therapy
20天前
已完结
Recent advances in optimizing siRNA delivery to hepatocellular carcinoma cells
1个月前
已完结
Non-Viral RNA Therapies for Non-Small Cell Lung Cancer and Their Corresponding Clinical Trials
1个月前
已完结
An updated patent review of MALT1 inhibitors (2021-present)
1个月前
已完结
Advances in Hepatocellular Carcinoma: Molecular Insights, Histologic Subtypes, and Differential Diagnosis
1个月前
已完结
Maternal Tmprss6 is required for hepcidin suppression and fetal health
1个月前
已关闭
RNA aggregates harness the danger response for potent cancer immunotherapy
2个月前
已完结
Selective and Potent Molecular Glue Degraders for NIMA‐related Kinase 7
3个月前
已完结
Expanding Conjugate Space of RNAi Therapeutics: Ligand at the 3′ End of the Antisense Strand Achieves Uncompromised In Vivo Potency and Efficacy and Reveals Interactions with the Argonaute-2 PAZ Domain
4个月前
已完结
皖公网安备34019202002308
